A.M. Vitals: Pfizer Likely to Spin Off, Not Sell, Animal-Health Business
The Wall Street Journal
This site uses cookies for performance, site traffic analysis, and social media purposes. Find out more about our cookie policy here. You can adjust your preferences in cookie settings.
